{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:17:20Z","timestamp":1790047040200,"version":"4.0.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2011,1,4]]},"DOI":"10.1212\/wnl.0b013e318203e9d1","type":"journal-article","created":{"date-parts":[[2010,12,27]],"date-time":"2010-12-27T21:29:23Z","timestamp":1293485363000},"page":"94-99","source":"Crossref","is-referenced-by-count":144,"title":["Quality improvement in neurology: AAN epilepsy quality measures"],"prefix":"10.1212","volume":"76","author":[{"given":"N.B.","family":"Fountain","sequence":"first","affiliation":[{"name":"From the Department of Neurology (N.B.F.), University of Virginia, Charlottesville; Department of Neurology (P.C.V.), University of Texas Southwestern Medical Center, Dallas; American Academy of Neurology (R.S.-E., S.T.), Saint Paul, MN; and Department of Neurology (C.T.B.), University of Maryland School of Medicine, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C.","family":"Van Ness","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (N.B.F.), University of Virginia, Charlottesville; Department of Neurology (P.C.V.), University of Texas Southwestern Medical Center, Dallas; American Academy of Neurology (R.S.-E., S.T.), Saint Paul, MN; and Department of Neurology (C.T.B.), University of Maryland School of Medicine, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Swain-Eng","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (N.B.F.), University of Virginia, Charlottesville; Department of Neurology (P.C.V.), University of Texas Southwestern Medical Center, Dallas; American Academy of Neurology (R.S.-E., S.T.), Saint Paul, MN; and Department of Neurology (C.T.B.), University of Maryland School of Medicine, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tonn","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (N.B.F.), University of Virginia, Charlottesville; Department of Neurology (P.C.V.), University of Texas Southwestern Medical Center, Dallas; American Academy of Neurology (R.S.-E., S.T.), Saint Paul, MN; and Department of Neurology (C.T.B.), University of Maryland School of Medicine, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"C.T.","family":"Bever","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (N.B.F.), University of Virginia, Charlottesville; Department of Neurology (P.C.V.), University of Texas Southwestern Medical Center, Dallas; American Academy of Neurology (R.S.-E., S.T.), Saint Paul, MN; and Department of Neurology (C.T.B.), University of Maryland School of Medicine, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the American Academy of Neurology Epilepsy Measure Development Panel and the American Medical Association\u2013Convened Physician Consortium for Performance Improvement Independent Measure Development Process","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb02586.x"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02480.x"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02422.x"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.09.064147"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.86"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-8-264"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000310815.29495.85"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2009.11.013"},{"key":"e_1_3_7_10_2","unstructured":"American Academy of Neurology\/American College of Radiology\/Physician Consortium for Performance Improvement\/National Committee for Quality Assurance. Stroke and Stroke Rehabilitation: Physician Performance Measure Set: 2006. Available at: http:\/\/www.ama-assn.org\/ama1\/pub\/upload\/mm\/370\/stroke-measures.pdf. Accessed May 3 2010."},{"key":"e_1_3_7_11_2","article-title":"Quality improvement in neurology: AAN Parkinson's Disease Quality Measures","author":"Cheng EM","unstructured":"Cheng EM, Tonn S, Swain-Eng R, et al.for the American Academy of Neurology Parkinson's Disease Measure Development Panel. Quality improvement in neurology: AAN Parkinson's Disease Quality Measures. Neurology (in press 2010).","journal-title":"Neurology"},{"key":"e_1_3_7_12_2","unstructured":"Physician Consortium for Performance Improvement Position Statement. Guidance for Requesting Physician Consortium for Performance Improvement\u00ae (PCPI) Review and Approval of Measures Developed Independently by PCPI Voting Members: 2007. Available at: http:\/\/www.ama-assn.org\/ama1\/pub\/upload\/mm\/370\/meas_dev_ind_pcpi.pdf. Accessed August 26 2010."},{"key":"e_1_3_7_13_2","unstructured":"Physician Consortium for Performance Improvement Position Statement. The evidence base required for measure development: 2009. Available at: http:\/\/www.ama-assn.org\/ama1\/pub\/upload\/mm\/370\/pcpi-evidence-based-statement.pdf. Accessed May 10 2010."},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055086.35806.2D"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000033622.27961.B6"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.8.1540"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.5.616"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a6b2f8"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000285084.93652.43"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.4.944"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000178391.96957.d0"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.4.666"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000285083.25882.0e"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2004.01.017"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01397.x"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00585.x"},{"key":"e_1_3_7_27_2","unstructured":"Stokes T Juarez-Garcia A Camosso-Stefinovic J Baker R. Clinical Guidelines and Evidence Review for the Epilepsies: Diagnosis and Management in Adults and Children in Primary and Secondary Care. London: Royal College of General Practitioners; 2004."},{"key":"e_1_3_7_28_2","unstructured":"Scottish Intercollegiate Guidelines Network. SIGN 70: (1) Diagnosis and management of epilepsy in adults. A national clinical guideline. (2) Diagnosis and management of epilepsy in adults. Update to printed guideline: 2004. Available at: http:\/\/www.sign.ac.uk\/pdf\/sign70.pdf. Accessed May 2008."},{"key":"e_1_3_7_29_2","unstructured":"Scottish Intercollegiate Guidelines Network. SIGN 81: The diagnosis and management of the epilepsies in children and young people: 2005. Available at: http:\/\/www.sign.ac.uk\/pdf\/sign81.pdf. Accessed May 2008."},{"key":"e_1_3_7_30_2","unstructured":"Singapore Ministry of Health. Epilepsy in adults: 2007. Available at: https:\/\/www.moh.gov.sg\/mohcorp\/uploadedFiles\/Publications\/Guidelines\/Clinical_Practice_Guidelines\/Diagnosis%20and%20Management%20of%20epilepsy%20in%20adults.pdf. Accessed May 2008."},{"key":"e_1_3_7_31_2","unstructured":"National Institute for Clinical Excellence. Newer drugs for epilepsy in adults: 2004. Available at: www.nice.org.uk\/TA076guidance. Accessed May 2008."},{"key":"e_1_3_7_32_2","unstructured":"National Institute for Clinical Excellence. Newer drugs for epilepsy in children: 2004. Available at: http:\/\/guidance.nice.org.uk\/TA79\/Guidance\/pdf\/English. Accessed May 2008."},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000291947.29643.9f"},{"key":"e_1_3_7_34_2","first-page":"2001","article-title":"Development of performance indicators for the primary care management of pediatric epilepsy: expert consensus recommendations based on the available evidence","volume":"14","author":"Caplin DA","year":"2006","unstructured":"Caplin DA, Rao JK, Filloux F, Bale JF, van Orman C. Development of performance indicators for the primary care management of pediatric epilepsy: expert consensus recommendations based on the available evidence. Epilepsia 2006;14:2001\u20132019.","journal-title":"Epilepsia"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e318203e9d1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:17:43Z","timestamp":1711631863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e318203e9d1"}},"subtitle":["Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology"],"short-title":[],"issued":{"date-parts":[[2011,1,4]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1,4]]}},"alternative-id":["10.1212\/WNL.0b013e318203e9d1"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e318203e9d1","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,4]]}}}